Rafael Holdings, INC. 8-K Filing

Ticker: RFL · Form: 8-K · Filed: Dec 2, 2025 · CIK: 1713863

Sentiment: neutral

Filing Stats: 552 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-12-02 07:32:16

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. In connection with the merger (the "Merger") with Cyclo Therapeutics, Inc. ("Cyclo"), Rafael Holdings, Inc. (the "Company") issued 1,078,796 warrants exercisable for an aggregate of 380,253 shares of the Company's Class B common stock (the "Warrants") at an exercise price of $14.19 per share in exchange for certain warrants to purchase Cyclo common stock (the "Cyclo Warrants"). The Warrants are listed on the NYSE American under the symbol "RFL-WT." The Cyclo Warrants were initially issued by Cyclo on December 11, 2020 in connection with its underwritten public offering. In connection with the Merger between the Company and Cyclo, the Cyclo Warrants were automatically converted into the Warrants to purchase shares of the Company's Class B common stock with the exercise price and number of shares issuable on exercise adjusted as per the exchange ratio used in the Merger. Each Warrant is exercisable for approximately .3525 (the exchange ratio used in the Merger) of a share of the Company's Class B common stock. The Warrants expire at 5:00 pm EST on December 11, 2025 and are exercisable at any time until such expiration. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAFAEL HOLDINGS, INC. By: /s/ David Polinsky Name: David Polinsky Title: Chief Financial Officer Dated: December 2, 2025 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing